Toxicity of peroxisomal C27-bile acid intermediates (Q39896739)

15 September 2017

Toxicity of peroxisomal C27-bile acid intermediates (English)

1 reference

15 September 2017

4

Ronald J A Wanders

1 reference

15 September 2017

1

Sacha Ferdinandusse

1 reference

15 September 2017

Simone Denis

2

1 reference

PubMed ID

19136287

15 September 2017

Georges Dacremont

series ordinal

3

1 reference

15 September 2017

10 January 2009

1 reference

Molecular Genetics and Metabolism

15 September 2017

1 reference

15 September 2017

96

1 reference

15 September 2017

3

1 reference

15 September 2017

121-128

1 reference

The enzymes, regulation, and genetics of bile acid synthesis

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Peroxisomes and bile acid biosynthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Rat liver bile acid CoA:amino acid N-acyltransferase: expression, characterization, and peroxisomal localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Human and rat bile acid-CoA:amino acid N-acyltransferase are liver-specific peroxisomal enzymes: implications for intracellular bile salt transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

The human bile acid-CoA:amino acid N-acyltransferase functions in the conjugation of fatty acids to glycine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Developmental changes of bile acid composition and conjugation in L- and D-bifunctional protein single and double knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Bile acid synthetic defects and liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Oral bile Acid treatment in two Japanese patients with Zellweger syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Oral bile acid treatment and the patient with zellweger syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Exploring Cells with a Centrifuge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Inhibition of oxidative phosphorylation by palmitoyl-CoA in digitonin permeabilized fibroblasts: implications for long-chain fatty acid β-oxidation disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Phytanic acid impairs mitochondrial respiration through protonophoric action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: application to mitochondrial encephalomyopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Mitochondrially mediated synergistic cell killing by bile acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Mitochondrially-mediated toxicity of bile acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Peroxisome biogenesis disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Peroxisomal disorders: the single peroxisomal enzyme deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Human hepatic mitochondria generate reactive oxygen species and undergo the permeability transition in response to hydrophobic bile acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.11.165

10.1016/J.YMGME.2008.11.165

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

19136287